Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study.
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
4
References
16
Citations
NaN
KQI